Hypophyllanthin

Hypophyllanthin
Product Name Hypophyllanthin
CAS No.: 33676-00-5
Catalog No.: CFN98431
Molecular Formula: C24H30O7
Molecular Weight: 430.5 g/mol
Purity: >=98%
Type of Compound: Lignans
Physical Desc.: Powder
Targets: P-gp | Calcium Channel | Potassium Channel | PGE
Source: The herbs of Phyllanthus niruri Linn.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $238/5mg
Hypophyllanthin and phyllanthin have antitumour effects against Ehrlich Ascites Carcinoma in mice. Hypophyllanthin can modulate the vascular tension via the endothelium-independent mechanisms, it can directly inhibit P-gp activity and does not interfere with MRP2 activity, it may reversibly inhibit P-gp function. Hypophyllanthin offers a promising means for treatment of chronic muscle pain. Hypophyllanthin also has estrogenic properties against carbofuran induced toxicity in female rats.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Int J Mol Sci.2023, 24(22):16465.
  • J Cosmet Dermatol.2022, 21(1):396-402.
  • Int J Mol Sci.2023, 24(18):14077.
  • Appl. Sci.2021, 11(24),12080
  • Bioorg Med Chem.2020, 28(12):115553.
  • J Pharm Biomed Anal2016, 118:183-194
  • Legume Science2021, 3(4): e101.
  • Molecules2022, 27(3),1140.
  • Evid Based Complement Alternat Med.2022, 2022:1307173.
  • Biocell2023, 47(8):1793-1802
  • Epischisandrone

    Catalog No: CFN95212
    CAS No: 98619-26-2
    Price: $413/5mg
    (-)-Holostyligone

    Catalog No: CFN90734
    CAS No: 887501-28-2
    Price: $318/5mg
    Dimethylwulignan A1

    Catalog No: CFN92718
    CAS No: 117404-43-0
    Price: Inquiry(manager@chemfaces.com)
    Phyltetralin

    Catalog No: CFN92069
    CAS No: 123048-17-9
    Price: Inquiry(manager@chemfaces.com)
    Isolintetralin

    Catalog No: CFN92070
    CAS No: 145459-30-9
    Price: Inquiry(manager@chemfaces.com)
    Nirtetralin

    Catalog No: CFN92852
    CAS No: 78185-63-4
    Price: Inquiry(manager@chemfaces.com)
    Hypophyllanthin

    Catalog No: CFN98431
    CAS No: 33676-00-5
    Price: $238/5mg
    (-)-Lyoniresinol

    Catalog No: CFN92578
    CAS No: 31768-94-2
    Price: Inquiry(manager@chemfaces.com)
    5-Methoxyisolariciresinol

    Catalog No: CFN96710
    CAS No: 136082-41-2
    Price: Inquiry(manager@chemfaces.com)
    Spathulatol

    Catalog No: CFN96566
    CAS No: 1373888-27-7
    Price: Inquiry(manager@chemfaces.com)
    J Pharm Pharmacol. 2013 Feb;65(2):292-9.
    Phyllanthin and hypophyllanthin inhibit function of P-gp but not MRP2 in Caco-2 cells.[Pubmed: 23278697]
    The purposes of this study were to investigate the inhibitory effects of two lignans, phyllanthin and Hypophyllanthin, on the function of P-glycoprotein (P-gp) and multidrug resistance protein 2 (MRP2), using the in-vitro model of Caco-2 cells. In addition, the effect of prolonged exposure to these two compounds on the expression of active P-gp was also determined.
    METHODS AND RESULTS:
    The activity of P-gp and MRP2 was determined in the uptake assays by monitoring the intracellular accumulation of their specific substrates (calcein acetoxymethyl ester and 5(6)-carboxy-2',7'-dichlorofluorescein diacetate, respectively) with fluorescence spectroscopy. Hypophyllanthin and phyllanthin inhibited P-gp function with comparable potencies, but neither compound affected MRP2 activity. When the lignans were washed out before addition of substrate, the inhibitory action of both compounds against P-gp function was lost. These results suggested the reversibility of the inhibition. Moreover, prolonged exposure of the Caco-2 cells to both lignans (up to 7 days) had no effect on P-gp function.
    CONCLUSIONS:
    Phyllanthin and Hypophyllanthin directly inhibited P-gp activity and did not interfere with MRP2 activity. It was likely that both phyllanthin and Hypophyllanthin could reversibly inhibit P-gp function.
    Fitoterapia. 2011 Dec;82(8):1231-6.
    Endothelium-independent effects of phyllanthin and hypophyllanthin on vascular tension.[Pubmed: 21893171]
    The purpose of this study was to investigate the modulating effects of phyllanthin and Hypophyllanthin on vascular tension, using in the in vitro model of isolated rat aorta.
    METHODS AND RESULTS:
    Our results indicated that both phyllanthin and Hypophyllanthin significantly relaxed the sustained contraction induced by phenylephrine (PE) in a concentration-dependent manner. In addition, endothelial removal had no significant influence on the vasorelaxation responses of the aortic rings toward these two compounds. Furthermore, both compounds inhibited the contraction of aortic muscle provoked by either PE (1 μM) or KCl (40 mM) as well as the spontaneous contraction of the Ca²⁺-depleted muscle. In high K⁺-Ca²⁺ free solution, phyllanthin (100 μM), but not Hypophyllanthin, significantly inhibited the contractile responses upon cumulative addition of CaCl₂. Both compounds (100 μM) significantly inhibited PE-induced contraction in Ca²⁺-free condition, but could not affect caffeine-induced contraction.
    CONCLUSIONS:
    Taken together, phyllanthin and Hypophyllanthin could modulate the vascular tension via the endothelium-independent mechanisms. The modulating effects of both compounds were possibly involved with the blockade of Ca²⁺ entry into vascular smooth muscle cells and inhibition of PE-mediated Ca²⁺ release from sarcoplasmic reticulum.
    Phytother Res. 2015 Aug;29(8):1202-10.
    Pain Modulation by Lignans (Phyllanthin and Hypophyllanthin) and Tannin (Corilagin) Rich Extracts of Phyllanthus amarus in Carrageenan-induced Thermal and Mechanical Chronic Muscle Hyperalgesia.[Pubmed: 25974715 ]
    The current study was aimed at evaluating the antihyperalgesic effects of lignans (phyllanthin and Hypophyllanthin) and tannin (corilagin) rich three standardized extracts of Phyllanthus amarus in a model of chronic musculoskeletal inflammatory pain.
    METHODS AND RESULTS:
    Three percent carrageenan injected in the gastrocnemius muscle produced hyperalgesia to mechanical and heat stimuli ipsilaterally, which spreads to the contralateral side within 7 to 9 days. To investigate the effects on chronic thermal and mechanical hypersensitivity, three extracts of P. amarus in three doses (100, 200, and 400 mg/kg) were administered to animals intraperitoneally from 14th day to 22nd day after intramuscular injection of carrageenan. It was observed that intraperitoneal administrations of Phyllanthus extracts showed antihyperalgesic activity, as they elevated thermal and mechanical threshold, which was supported by histopathological observations along with reduction in prostaglandin E2 (PGE2) concentration.
    CONCLUSIONS:
    In conclusion, we strongly suggest that the observed antihyperalgesic and antiinflammatory effects of P. amarus in current pain model are mediated via spinal or supraspinal neuronal mechanisms, mainly by inhibition of PGE2. Modulation of chronic muscular inflammation may be due to presence of phytoconstituents like phyllanthin, Hypophyllanthin, and corilagin, which offers a promising means for treatment of chronic muscle pain.
    Pharmacologyonline, 2008, 2:796-807.
    Antitumour effect of Phyllanthin and Hypophyllanthin from Phyllanthus amarus against Ehrlich Ascites Carcinoma in mice.[Reference: WebLink]

    METHODS AND RESULTS:
    A mixture (1:1) of Phyllanthin and Hypophyllanthin isolated from Phyllanthus amarus (P. amarus) exhibited antitumor activities against Ehrlich Ascites Carcinoma in Swiss albino mice. Animals were pre-treated orally with the extract at a dose of 25mg/kg, 50 mg/kg, 100mg/kg body weight and then after 24hrs after EAC (at a dose of 2 × 10 6 cells/ mouse) administration and following an 18hr fasting; mice were sacrificed for studying of antitumor activity. The decrement of tumor volume, and packed cell volume and viable cell count were observed in lignans treated mice when compared only to EAC tumor bearing mice. Treatment with test compounds increased the survival time and normal peritoneal cell count. Hematological parameters, PCV which were altered by tumor volume inoculation, were restored considerably.
    CONCLUSIONS:
    Thus, this study was an attempt to evaluate the preventive and curative role of P.amarus lignans in tumor bearing mice.
    J Nat Prod. 1993 Feb;56(2):233-9.
    1H- and 13C-nmr assignments of phyllanthin and hypophyllanthin: lignans that enhance cytotoxic responses with cultured multidrug-resistant cells.[Pubmed: 8385184]

    METHODS AND RESULTS:
    Complete 1H-nmr data and unambiguous assignments of the 13C-nmr spectra of phyllanthin [1] and Hypophyllanthin [2] were obtained through extensive nmr studies, including homonuclear COSY, homonuclear decoupling, APT, HETCOR, nOe difference, selective INEPT, and COLOC experiments. The absolute configuration of Hypophyllanthin [2] was determined by cd.
    CONCLUSIONS:
    Neither of these lignans demonstrated significant cytotoxic activity when evaluated with a battery of cultured mammalian cells, but both were found to enhance the cytotoxic response mediated by vinblastine with multidrug-resistant KB cells. In addition, 1 was found to displace the binding of vinblastine with membrane vesicles derived from this cell line, suggesting an interaction with the P-glycoprotein.
    Magnaldehyde B

    Catalog No: CFN95075
    CAS No: 92829-72-6
    Price: $318/5mg
    8-Hydroxypinoresinol diglucoside

    Catalog No: CFN95083
    CAS No: 112747-99-6
    Price: $318/5mg
    Pueroside C

    Catalog No: CFN95156
    CAS No: 112343-16-5
    Price: $368/5mg
    N-trans-caffeoyltyramine

    Catalog No: CFN95265
    CAS No: 103188-48-3
    Price: $318/5mg
    Solafuranone

    Catalog No: CFN95312
    CAS No: 367965-50-2
    Price: $318/5mg
    Physalin X

    Catalog No: CFN95329
    CAS No: 72497-31-5
    Price: $318/5mg
    Ganoderic acid GS-3

    Catalog No: CFN95518
    CAS No: 1206781-66-9
    Price: $413/5mg
    Hosenkoside L

    Catalog No: CFN95520
    CAS No: 161016-50-8
    Price: $318/10mg
    Hainanic acid B

    Catalog No: CFN95526
    CAS No: 1637737-46-2
    Price: $413/5mg
    N-Demethylfordianoside

    Catalog No: CFN95589
    CAS No: N/A
    Price: $318/10mg